Zobrazeno 1 - 10
of 390
pro vyhledávání: '"Per Morten, Sandset"'
Autor:
Sean P. Harrison, Richard Siller, Yoshiaki Tanaka, Maria Eugenia Chollet, María Eugenia de la Morena-Barrio, Yangfei Xiang, Benjamin Patterson, Elisabeth Andersen, Carlos Bravo-Pérez, Henning Kempf, Kathrine S. Åsrud, Oleg Lunov, Alexandr Dejneka, Marie-Christine Mowinckel, Benedicte Stavik, Per Morten Sandset, Espen Melum, Saphira Baumgarten, Flavio Bonanini, Dorota Kurek, Santosh Mathapati, Runar Almaas, Kulbhushan Sharma, Steven R. Wilson, Frøydis S. Skottvoll, Ida C. Boger, Inger Lise Bogen, Tuula A. Nyman, Jun Jie Wu, Ales Bezrouk, Dana Cizkova, Javier Corral, Jaroslav Mokry, Robert Zweigerdt, In-Hyun Park, Gareth J. Sullivan
Publikováno v:
Experimental and Molecular Medicine, Vol 55, Iss 9, Pp 2005-2024 (2023)
Abstract The lack of physiological parity between 2D cell culture and in vivo culture has led to the development of more organotypic models, such as organoids. Organoid models have been developed for a number of tissues, including the liver. Current
Externí odkaz:
https://doaj.org/article/807e8461f64a4203a1ae380b8b984277
Autor:
Giacomo Roman, Benedicte Stavik, Knut H. Lauritzen, Per Morten Sandset, Sean P. Harrison, Gareth J. Sullivan, Maria Eugenia Chollet
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
The bleeding phenotype of hereditary coagulation disorders is caused by the low or undetectable activity of the proteins involved in hemostasis, due to a broad spectrum of genetic alterations. Most of the affected coagulation factors are produced in
Externí odkaz:
https://doaj.org/article/189be6693172497289e5f8079ec8090c
Autor:
Xue Yan Cui, Geir Erland Tjønnfjord, Sandip M. Kanse, Anders Erik Astrup Dahm, Nina Iversen, Christiane Filion Myklebust, Ling Sun, Zhong Xing Jiang, Thor Ueland, James J. Campbell, Mitchell Ho, Per Morten Sandset
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The infiltration of chronic lymphocytic leukemia (CLL) cells into lymphoid organs correlates with disease severity. CXCL12 is a key chemotactic factor for the trafficking of CLL. Tissue factor pathway inhibitor (TFPI) is a serine protease in
Externí odkaz:
https://doaj.org/article/ce0caf0c3fe64d058cc6da40b15f9c56
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Post-thrombotic syndrome (PTS) is a frequent chronic complication of proximal deep vein thrombosis (DVT) of the lower limb, but predictors of PTS are not well established. We aimed to examine predictors of PTS in patients with lon
Externí odkaz:
https://doaj.org/article/787e7361ca974363a19cca5338605c99
Autor:
Lamya Garabet, Waleed Ghanima, Marit Hellum, Per Morten Sandset, James B. Bussel, Hoa Tran, Carola E. Henriksson
Publikováno v:
Platelets, Vol 31, Iss 3, Pp 322-328 (2020)
Immune thrombocytopenia (ITP) patients have thrombocytopenia and increased bleeding risk, but, conversely, they also have increased thrombotic risk which appears to be exacerbated by thrombopoietin-receptor agonist (TPO-RA)-treatment. Microvesicles (
Externí odkaz:
https://doaj.org/article/a6901082dfdb441ea417575e609ff301
Autor:
Lamya Garabet, Waleed Ghanima, Anbjørg Rangberg, Raul Teruel-Montoya, Constantino Martinez, Maria Luisa Lozano, Camilla F. Nystrand, James B. Bussel, Per Morten Sandset, Christine M. Jonassen
Publikováno v:
Platelets, Vol 31, Iss 2, Pp 198-205 (2020)
MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of gene expression. Dysregulated expression of several miRNAs has been found in primary immune thrombocytopenia (ITP) suggesting that miRNAs are likely involved in the pathogenes
Externí odkaz:
https://doaj.org/article/a8519fca27444168b9f042182b7e599d
Autor:
Nina Haagenrud Schultz, Pål Andre Holme, Stine Bjørnsen, Carola Elisabeth Henriksson, Per Morten Sandset, Eva-Marie Jacobsen
Publikováno v:
Platelets, Vol 31, Iss 1, Pp 43-47 (2020)
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for bleeding. For instance, while the risk of major bleeding in general may be lower with rivaroxab
Externí odkaz:
https://doaj.org/article/06d2a660183045189d5073ccaf09412f
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 13706 (2022)
Factor-VII-activating protease (FSAP) is involved in the regulation of hemostasis and inflammation. Extracellular histones play a role in inflammation and the conversion of latent pro-FSAP into active FSAP. FSAP has been shown to regulate endothelial
Externí odkaz:
https://doaj.org/article/8d2161e049dd40da822a415ecedff954
Autor:
Elisabeth Andersen, Maria Eugenia Chollet, Marcello Baroni, Mirko Pinotti, Francesco Bernardi, Ellen Skarpen, Per Morten Sandset, Grethe Skretting
Publikováno v:
Cell & Bioscience, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Congenital coagulation factor (F) VII deficiency is a rare bleeding disorder caused by mutations in the F7 gene. The missense factor FVII variant p.Q160R is the disease-causing mutation in all Norwegian FVII deficient patients and
Externí odkaz:
https://doaj.org/article/4a50b5a4e4e8408885bef2123e0f9982
Autor:
Lamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, Vibe Skov, René Holst, Marie-Christine Mowinckel, Hans C. Hasselbalch, Torben A. Kruse, Mads Thomassen, Howard Liebman, James B Bussel, Per Morten Sandset
Publikováno v:
Platelets, Vol 30, Iss 2, Pp 206-212 (2019)
Thrombopoietin-receptor-agonists (TPO-RA) are effective treatments of immune thrombocytopenia (ITP). Previous long-term TPO-RA clinical trials have shown that thrombotic events occurred in 6% of TPO-RA-treated ITP patients. To explore the increased r
Externí odkaz:
https://doaj.org/article/13533f98444047fdb2b1fe79d7167808